REG - Cambridge Cognition - Result of AGM and Board Changes
RNS Number : 0711ACambridge Cognition Holdings PLC27 May 202127 May 2021
Cambridge Cognition Holdings Plc
("Cambridge Cognition" or the "Company")
Result of AGM and Board Changes
Cambridge Cognition, which develops and markets digital solutions to assess brain health, held its Annual General Meeting ("AGM") earlier today at the registered office of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. All resolutions put to the AGM were duly passed. The votes received in respect of each resolution were as follows:
Resolution
For
Against
Withheld
1
17,216,587
100.0%
0
0.0%
0
2
17,198,361
100.0%
0
0.0%
18,226
3
17,216,587
100.0%
0
0.0%
0
4
17,134,455
100.0%
0
0.0%
82,132
5
17,152,681
99.6%
63,906
0.4%
0
6
17,152,681
99.6%
63,906
0.4%
0
Confirmation of Board Changes
As notified in January 2021, Nicholas Walters resigned as a Director with effect from the end of the AGM. Nick has been a member of the Board for seven years and until January this year was Chief Financial Officer. Both the Company and the Board are grateful for his support over this time and wish him well for the future.
As announced on 19 January 2021 the Company appointed Michael (Mick) Holton as Chief Financial Officer, effective from that date. It is anticipated that Mick will shortly join the Company's Board and a further announcement will be made as appropriate.
Enquiries
Cambridge Cognition Holdings PLC
Matthew Stork, Chief Executive Officer
Michael Holton, Chief Financial Officer
Tel: 01223 810 700
finnCap Ltd (NOMAD and Joint Broker)
Geoff Nash / Simon Hicks
Alice Lane / Charlotte Sutcliffe
Tel: 020 7220 0500
(Corporate Finance)
(Corporate Broking)
Dowgate Capital Limited (Joint Broker)
David Poutney / James Serjeant
Tel: 020 3903 7715
IFC Advisory Ltd (Financial PR and IR)
Tim Metcalfe / Graham Herring / Zach Cohen
Tel: 020 3934 6630
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDRAGARMBTMTATBAB
Recent news on Cambridge Cognition Holdings
See all newsREG - Cambridge Cognition - Preliminary Results, Trading Update & Board Change
AnnouncementREG - Cambridge Cognition - Notice of Results
AnnouncementREG - Cambridge Cognition - COG spin-out Monument Therapeutics accesses £1.5m
AnnouncementREG - Cambridge Cognition - Total Voting Rights and Block Listing Return
AnnouncementREG - Cambridge Cognition - Formation of new Scientific Advisory Board
Announcement